Project CBD

NOVEMBER 7, 2018

How often have we heard, “More research is needed,” from those who would prefer to see no change in policies that should be informed by science? From climate denial to cannabis prohibition, the demand for absolute scientific certainty is a call for inaction. It begs the question: When is there “enough” research? How about not enough to eliminate all uncertainties, but enough to recommend medical treatment or change policy?

Epilepsy 272

Epilepsy Policy Treatment Cannabis 272

Medicinal Marijuana Association

NOVEMBER 7, 2018

In the last few years, there has been growing interest in cannabis and what it can do in the medical field. More research than ever before is being conducted, and more medical professionals are beginning to embrace it as a potential treatment for their patients.

Treatment 58

Treatment Marijuana Patients Cannabis 58

Project CBD

NOVEMBER 7, 2018

How often have we heard, “More research is needed,” from those who would prefer to see no change in policies that should be informed by science? From climate denial to cannabis prohibition, the demand for absolute scientific certainty is a call for inaction. It begs the question: When is there “enough” research? How about not enough to eliminate all uncertainties, but enough to recommend medical treatment or change policy?

Epilepsy 228

Epilepsy Policy Treatment Cannabis 228

SMPL

NOVEMBER 7, 2018

See the results for each state below: Michigan Passes. North Dakota fails. Missouri Passes. Utah Passes.

40

40

Speaker: Jonathan Bench, International Cannabis and Securities Business Attorney at Harris Bricken

The U.S. cannabis industry is still in its infancy, even though states began engaging with legalization in one form or another in the late 1990s. Today, many opportunities exist for individuals and businesses that want to engage in the industry. Some want to directly own licensed businesses, while others prefer to keep the industry at an arm’s length and merely profit from it.

Cannabis